Europe Enteral Nutrition Market Forecast to 2030 - Regional Analysis - by Product Type, Application, Age Group, and Distribution Channel

The Europe enteral nutrition market was valued at US$2.45 billion in 2022 and is expected to reach US$3.86 billion by 2030; it is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

Rising Cases of Malnutrition and Premature Births Fuel Europe Enteral Nutrition Market

Undernourished, overweight or obese, vitamin or mineral deficiency, and poor diet-related noncommunicable diseases are all categorized under malnutrition. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had slow growth and development owing to the chronic lack of access to nutritious food, and 45 million were wasted (too thin for height). ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data by the United Nations International Children's Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021.

According to a Specialized Nutrition Europe study, nearly 40% of hospitalized adult patients were malnourished in Europe in 2019. nearly 11-45% of patients in hospitals and home care settings in England suffered from malnutrition. Nutritional support can be delivered through enteral means, depending on the need, which is an essential and appropriate way of treating most malnutrition cases. Thus, the massive burden of malnutrition in children and adults drives the demand for enteral nutrition formulae and products.

As per WHO data published in 2023, ~13.4 million preterm births (more than 1 in 10 births) were reported worldwide in 2020. On average, 12% of births in low-income countries and 9% in high-income countries are premature births. A large number of premature babies suffer from low weight and undeveloped immunity, which puts their lives at risk. Most medical guidelines advise enteral nutrition for supporting the optimal growth of preterm infants if they are unable to drink, suck, swallow, and breathe. Hence, the demand for enteral nutrition is growing with the increasing number of cases of preterm births.

Europe Enteral Nutrition Market Overview

The Europe enteral nutrition market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe holds a significant position in the global enteral nutrition market and is estimated to register a robust CAGR during 2022-2030. Market growth in this region is mainly attributed to the increasing geriatric population, rising incidence of chronic diseases and neurological disorders such as stroke and cerebral aneurysms, and product innovations by the players operating in the region.

Nutritional deficiencies leads to unfavorable outcomes and lower quality of life in patients with malignancies. Patients with active tumors often lack sufficient food. To prevent or reduce progressive weight loss, enteral nutrition and parenteral nutrition are the therapeutic objectives. According to the Association of the Scientific Medical Societies in Germany, patients with severe gastrointestinal defects, such as radiation enteritis, can benefit from parenteral nutrition. In most cases, artificial nutrition stabilizes or increases body weight and body fat mass.

Europe Enteral Nutrition Market Segmentation

The Europe enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.

Based on product type, the Europe enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger Europe enteral nutrition market share in 2022.

In terms of application, the Europe enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest Europe enteral nutrition market share in 2022.

Based on age group, the Europe enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger Europe enteral nutrition market share in 2022.

By distribution channel, the Europe enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest Europe enteral nutrition market share in 2022.

Based on country, the Europe enteral nutrition market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe enteral nutrition market in 2022.

Abbott Laboratories, Arla Foods amba, B Braun SE, Danone SA, Dr Schar AG, Fonterra Co-Operative Group Ltd, Fresenius SE & Co KGaA, Nestle SA, Perrigo Co Plc, Reckitt Benckiser Group Plc, and Royal FrieslandCampina NV are some of the leading companies operating in the Europe enteral nutrition market.